Targeted sequencing and finding drugable mutations
21 Jul 2011
Targeted sequencing and finding drugable mutations
Development of a lung cancer blood test
Mulit-drug international clinical trials
New anti-cancer drugs at Nerviano Medical Sciences
WIN 2011: Efficacy of diagnostics and therapeutics
Worldwide biobanking
Changing drug discovery: share data
WIN 2011: Personalised medicine and a global biomarker database
Early stage molecular profiling
Emergence of ipilimumab and vemurafenib for melanoma
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life
Advances in the treatment of multiple myeloma